United States· US:60505-2521_a10eb847-1c2f-7cdf-4274-81e6e3aab180

cilostazol

A cilostazol product containing cilostazol, registered in United States by Apotex Corp.. The same ATC class is registered in 8 of our 19 countries.

ATC B01AC23

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedcilostazolATCB01AC23REGISTER NO.US:60505-2521_a10eb84…PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Cilostazol is registered in 8 of 19 countries.

Countries holding a registration under ATC B01AC23 (cilostazol), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 5 of them publish a price we can compare per daily dose

Cilostazol · ATC B01AC23

8 / 19 countries

  • Czechiaprice
  • Germany
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cilostazol costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Cilostazol · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • ES Spain$0.85
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CILOSTAZOL
Manufacturer
Apotex Corp.
Country
United States (US)
ATC code
B01AC23
ATC class
Cilostazol
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 3

  • ndc11
    60505-2521-1
  • ndc11
    60505-2521-3
  • ndc11
    60505-2521-8

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

490 interactions on record for cilostazol.

Graded by severity as the source publishes them — 147 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cilostazol · interactions on record

490 records

  • 147 severe
  • 336 moderate
  • 7 minor

Most severe, free to view

  • OmeprazoleA02BC01severe
  • LansoprazoleA02BC03severe
  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cilostazol in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cilostazol products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Bulgaria · Лостразин, Тромбай
  • Czechia · Cilostazol Stada, Noclaud
  • Germany · Cilostazol Al, Cilostazol Stada
  • Estonia · Cilostad, Cilostazol Stada
  • Spain · Acetival, Cilostazol Aristo
  • United Kingdom (Northern Ireland) · Cilostazol
  • Greece · Cilos, Cilostazol Galenica
  • Hungary · Antaclast, Cilostazol Teva
  • Italy · Albaten, Cilostazolo Eg
  • Lithuania · Dilsatan, Sollazon
  • Latvia · Dilsatan, Sollazon
  • Malta · Cilostazol, Cilostazol Libytec
  • Poland · Cilostazol Lek-Am, Cilostop
  • Portugal · Cilostazol Ferrer
  • Romania · Dilvas, Velyn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/444ebe7b-3e35-4502-bd91-3d3cc4569e01
GET /v1/drugs/444ebe7b-3e35-4502-bd91-3d3cc4569e01?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "50",
  "substance": "CILOSTAZOL",
  "productndc": "60505-2521",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA077030",
  "marketing_category": "ANDA"
}

See everything about cilostazol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.